TITLE

Hypertension

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS38
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Evaluation of the antihypertensive effects of the angiotensin II antagonist tasosartan: A randomized, double-blind placebo-controlled, dose ranging, parallel-group, multicenter trial,' by Y. Lacourciere and L. Poirier.
ACCESSION #
9708236259

 

Related Articles

  • Angiotensin-receptor blocker (Major drug group).  // Royal Society of Medicine: Medicines;2002, p62 

    The article presents information on angiotensin-receptor blocker drugs. The drugs work by blocking angiotensin receptors. Recently introduced drugs of this type include: candesartan, cilexetil, eprosartan, irbesartan, losartan, potassium, telmisartan and valsartan, which can be used as...

  • Diovan.  // Royal Society of Medicine: Medicines;2002, p206 

    This article presents information on the drug Diovan, a proprietary, prescription-only preparation of the angiotensin-receptor blocker valsartan. It can be used as an antihypertensive, and is available in capsules.

  • Angiotensin blockade by saralasin bolus injection. Maxwell, Morion H.; Marks, Leonard S. // Kidney International Supplement;Mar1979, Issue 9, p53 

    Discusses the method of saralasin bolus test (SBT). Discontinuation of all antihypertensive and diuretic medication in advance of the test to allow complete clearance from the body; Interpretation of SBT; SBT versus preinjection level determination.

  • Drug interactions with saralasin. Mitchell, Helen C.; Keeton, T. Kent; Pettinger, William A. // Kidney International Supplement;Mar1979, Issue 9, p101 

    Diuretic and vasodilator drugs alter the BP response to saralasin causing drug interactions. Saralasin-induced BP reduction is related directly to PRA and intravascular volume. Diuretic agents deplete intravascular volume and elevate PRA, enhancing saralasin hypotension. Vasodilating agents...

  • Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors. Magaldi, A. J.; Cesar, K. R.; e Araújo, M.; e Silva, A. C. Simões; Santos, R. A. S. // Pflugers Archiv European Journal of Physiology;Nov2003, Vol. 447 Issue 2, p223 

    The peptide angiotensin-(1–7) [Ang-(1–7)] is known to enhance water transport in rat inner medullary collecting duct (IMCD). The aim of this study was to determine the mechanism of the Ang-(1–7) effect on osmotic water permeability (Pf). Pf was measured in the normal rat...

  • Angiotensin II profiling with saralasin: Summary of Eaton Collaborative Study. Horne, Melvin L.; Conklin, Vincent M.; Keenan, Robert E.; Varady, Paul D.; DiNardo, Joseph // Kidney International Supplement;Mar1979, Issue 9, p115 

    Saralasin testing, a significant new approach for eliciting the role of All, was tested against a standard workup for renovascular hypertension—an accepted "model" of angiotensin-dependent hypertension. Comparison showed that results of the procedure correlated closely with...

  • Antihypertensive/DM link weakest for ARAs, ACE inhibitors.  // Reactions Weekly;1/27/2007, Issue 1136, p1 

    The article discusses research being done on the association of angiotensin receptor antagonists (ARA) and angiotensin converting enzyme (ACE) inhibitors with incident diabetes mellitus (DM). It references a study by W. J. Elliott et al published in the January 20, 2007 issue of the journal...

  • Diuretic Therapy and Response of Essential Hypertension to Saralasin. Anderson Jr., Gunnar H.; Dalakos, Theodore G.; Elias, Alan; Tomycz, Nestor; Streeten, David H. P. // Annals of Internal Medicine;Aug77, Vol. 87 Issue 2, p183 

    Thirty-four patients, most with a low-renin "essential" hypertension, and seven normal subjects were placed on diuretic therapy for 4 to 5 weeks. In the normal subjects, infusion of a highly specific, competitive angiotensin 11 analogue (1-sar-8-ala-anglotensin II, saralasin) did not...

  • Angiotensin II control of the renal microcirculation: Effect of blockade by saralasin. Steinhausen, Michael; Kücherer, Helmut; Parekh, Niranjan; Weis, Stefan; Wiegman, David L.; Wilhelm, Karl-Rainer // Kidney International;Jul1986, Vol. 30 Issue 1, p56 

    The hydronephrotic rat kidney with intact circulation and innervation was split and spread out as a thin sheet in a tissue bath. The microvasculature was observed in vivo via television microscopy. We quantitated the effects of increasing concentrations (10-9 to 10-5 M) of saralasin (angiotensin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics